Opko Health (OPK) Enterprise Value (2010 - 2026)

Opko Health has reported Enterprise Value for 17 years, with the latest figure at -$341.9 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value rose 21.59% year-over-year to -$341.9 million; the trailing twelve-month figure through Mar 2026 stood at -$341.9 million (up 21.59% YoY), and the FY2025 full-year result was -$369.1 million, up 14.55% from the prior year.
• Enterprise Value for Q1 2026 stood at -$341.9 million, up from -$369.1 million in the prior quarter.
• The five-year high for Enterprise Value was -$40.6 million in Q2 2024, with the low at -$436.0 million in Q1 2025.
• Historically, Enterprise Value has averaged -$228.7 million across 5 years, with a median of -$180.8 million in 2022.
• Annual changes were most pronounced in 2024 — Enterprise Value soared 62.47% — and 2025, when it slumped 569.65%.
• Opko Health's Enterprise Value stood at -$153.2 million in 2022, then jumped by 37.41% to -$95.9 million in 2023, then plunged by 350.49% to -$431.9 million in 2024, then climbed by 14.55% to -$369.1 million in 2025, then rose by 7.37% to -$341.9 million in 2026.
• The last three Enterprise Value figures came in at -$341.9 million (Q1 2026), -$369.1 million (Q4 2025), and -$415.2 million (Q3 2025), per Business Quant data.